Skip to content
Cart

Your Cart

×

You have 0 items in your cart.

Register Sign in Wishlist

Ethics and the Pharmaceutical Industry

$41.99 (P)

Thomas Abrams, Charles L. Bardes, Valentine J. Burroughs, Glenna Crooks, Norman Daniels, Scott D. Danzis, Martin Delaney, Don E. Detmer, Julie M. Donohue, Jurgen Drews, Sev Fluss, William Foege, Sara F. Goldkind, James Thuo Gathii, Michael Gorman, Thomas M. Gorrie, Joel Hay, The Hon. Rush Holt, Nien-he Hsieh, Juhana E. Indapaan-Heikkila, Greg Koski, M. Dianne Murphy, Robert M. Nelson, Gary R. Noble, Scott C. Ratzan, Meredith B. Rosenthal, James E. Sabin, Michael A. Santoro, Peter Singleton, J. Russell Teagarden, Sidney Taurel, Patricia H. Werhane, William Weldon
View all contributors
  • Date Published: July 2007
  • availability: Available
  • format: Paperback
  • isbn: 9780521708883

$ 41.99 (P)
Paperback

Add to cart Add to wishlist

Other available formats:
Hardback, eBook


Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact collegesales@cambridge.org providing details of the course you are teaching.

Description
Product filter button
Description
Contents
Resources
Courses
About the Authors
  • Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Debates are raging over how the industry can and should be expected to act. In this volume leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, marketing and advertising. . Michael Santoro is Associate Professor with tenure in the Business Environment Department at Rutgers Business School, where he teaches courses on business ethics, public policy, labor and human rights, law, ethical issues in the pharmaceutical industry and China business strategy. As a Research Associate at Harvard Business School, he wrote or co-authored nearly thirty case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines and Fair Credit Reporting Act. Thomas Gorrie is Corporate Vice President, Government Affairs & Policy, at Johnson & Johnson, with responsiblity for all federal, state and international government affairs and policy. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich, following the receipt of his doctorate at Princeton University. Gorrie has over 30 years of worldwide health care experience and has worked with various Johnson & Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international, venture capital, and health policy.

    • Extremely topical, accessible collection on drug pricing, safety, marketing, advertising, and patenting
    • First book to bring together high-level representatives of industry, government, NGOs, leading thinkers in medicine, health ethics, and economics
    • Authors propose solutions - safeguards, ethical guidelines and other recommendations - to the ethical problems of drug companies in society
    Read more

    Reviews & endorsements

    "Santoro and Gorrieas book tackles one of the most controversial issues affecting our society 'healthcare: an economic commodity or basic human right?' At the heart of this debate is the role of the pharmaceutical industry. The book highlights effectively the opposing forces underlying the tension between the need for financial incentive for drug discovery and the global need for affordable medicines. It succeeds in providing provocative yet balanced perspectives from leaders of industry, government, ethics, business and healthcare. This book is a must read."
    -Dr. Victor J. Dzau, President and Chief Executive Officer, Duke University Health System and Chancellor for Health Affairs, Duke University Medical Center

    "For intelligent debate on the crisis of confidence in Big Pharma, this volume is unsurpassed. Santoro and Gorrie have assembled an impressive array of voices to tackle contentious issues plaguing the industry, from physician professionalism and research integrity to drug pricing, direct-to-consumer advertising, and intellectual property rights. Combining rigorous analysis with provocative proposals for change, this timely volume should be prescribed reading for industry leaders, policy-makers, and citizens alike."
    -Lynn S. Paine, John G. McLean Professor of Business Administration, Harvard Business School

    "This book provides thoughtful dialogue from diverse viewpoints on some of the most significant issues in health care -- we need this kind of meaningful dialogue to happen more often."
    -Tommy G. Thompson, Former Secretary of Health and Human Services and Former Governor of Wisconsin

    "Michael Santoro and Thomas Gorrie have compiled a series of essays that provide a fair, balanced, and insightful examination of an increasingly troubled relationship between the pharmaceutical industry and society."
    -Henry Thomas Stelfox, Journal of the American Medical Association

    "Ethics and the Pharmaceutical Industry is a timely and thoughtful addition to the growing literature on this controversial subject...I highly recommend this collection of essays as a beginning of a pathway for all parties involved in healthcare."
    -Alan T. Kaell, Pharmacy and Therapeutics

    "Suffice it to say the book has something in it for almost everyone interested in health care, ethics, and pharmaceuticals. You will learn something from some of the authors, while others will likely make you mad. But they all make you think."
    -Merrill Matthews, Journal of the National Association for Business Economics

    "Santoro and Gorrie have woven together a rich collection of perspectives in Ethics and the Pharmaceutical Industry, with contributors ranging from activists and academicians to regulators and representatives from the industry."
    -Jeremy Sugarman, Johns Hopkins University, The New England Journal of Medicine

    "Santoro, Gorrie and their contributors succeed in assembling a text that presents the key issues of business conduct for multinational pharmaceutical corporations, in a spirit of dialogue and respect for truly diverse perspectives."
    -William Avery Hudson blog

    "A timely and fair-minded overview of many drug-related issues."
    -Future Survey

    See more reviews

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Date Published: July 2007
    • format: Paperback
    • isbn: 9780521708883
    • length: 528 pages
    • dimensions: 229 x 152 x 30 mm
    • weight: 0.68kg
    • availability: Available
  • Table of Contents

    Charting a sustainable path for the 21st century pharmaceutical industry Michael A. Santoro
    Part I. Profits, Patients' Rights, and Scientific Progress: The Ethics of Clinical Research Conducted in Private Enterprises:
    1. Drug research: between ethical demands and economic constraints Jurgen Drews
    2. Emerging international norms for clinical testing: good clinical trial practice Juhana E. Idanpaan-Heikkila and Sev S. Fluss
    3. The regulatory and ethical challenges of pediatric research M. Dianne Murphy and Sara F. Goldkind
    4. Including children in research: participation or exploitation? Robert M. Nelson
    5. Racial and ethnic inclusiveness in clinical trials Valentine J. Burroughs
    6. The rights of patients to participate in clinical trials Glenna Crooks
    7. How should government regulate stem-cell research? Perspectives of a scientist-legislator The Hon. Rush Holt
    Part II. Marketing and the Efficient Utilization of Healthcare Resources: Ethical and Public Policy Challenges:
    8. Ethics and prescribing: the clinician's perspective Charles L. Bardes
    9. Direct-to-consumer advertising of prescription drugs: a policy dilemma Meredith B. Rosenthal and Julie M. Donohue
    10. Regulation of prescription drug promotion Thomas Abrams
    11. Off-label communications in marketing prescription drugs Scott D. Danzis
    12. The need for better health information: advancing the informed patient in Europe Don E. Detmer, Peter Singleton and Scott C. Ratzan
    13. Who should get access to which drugs? An ethical template for pharmacy benefits Norman Daniels, James E. Sabin and J. Russell Teagarden
    14. The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals Joel Hay
    Part III. Patents, Pricing, and Equal Access:
    15. Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities Patricia H. Werhane and Michael Gorman
    16. A future agenda for government-industry relations William Weldon
    17. AIDS activism and the pharmaceutical industry Martin Delaney
    18. The campaign against innovation Sidney Taurel
    19. Third world perspectives on global pharmaceutical access James Thuo Gathii
    20. The promise of vaccines and the influenza shortage of 2004: public and private partnerships Gary R. Noble
    Part IV. Charting a Sustainable Path for the 21st Century:
    21. Evolving approaches to healthcare challenges Thomas M. Gorrie
    22. Property rights in crisis: managers and rescue Nien-he Hsieh
    23. Blurring the lines: public and private partnerships addressing global health William Foege
    24. Renegotiating the grand bargain: balancing prices, profits, people, and principles Greg Koski.

  • Authors

    Michael A. Santoro, Rutgers University, New Jersey
    Michael A. Santoro is Associate Professor with tenure in the Business Environment Department at Rutgers Business School, where he teaches courses on business ethics, public policy, labor and human rights, law, ethical issues in the pharmaceutical industry, and China business strategy. Professor Santoro holds a PhD in Public Policy from Harvard University and a JD from the New York University School of Law. As a Research Associate at Harvard Business School, he wrote or co-authored nearly 30 case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines, and the Fair Credit Reporting Act. Professor Santoro has also published numerous journal articles, op-ed articles, and book chapters on these topics in publications such as Foreign Policy, and Human Rights Quarterly. He is the author of Profits and Principles: Global Capitalism and Human Rights in China (2000).

    Thomas M. Gorrie
    Thomas M. Gorrie is Corporate Vice President, Government Affairs and Policy at Johnson and Johnson, with responsibility as Corporate Officer for all federal, state, and international government affairs and policy. He has over 30 years of worldwide health care experience. He has worked with various Johnson and Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international venture capital, and health policy. Dr Gorrie received his PhD in chemistry from Princeton University. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich. He serves on numerous non-profit boards, including Duke University Health Care System, Robert Wood Johnson University Hospital, the Dean's Advisory Board of the Rutgers Business School, and the Hun School of Princeton.

    Contributors

    Thomas Abrams, Charles L. Bardes, Valentine J. Burroughs, Glenna Crooks, Norman Daniels, Scott D. Danzis, Martin Delaney, Don E. Detmer, Julie M. Donohue, Jurgen Drews, Sev Fluss, William Foege, Sara F. Goldkind, James Thuo Gathii, Michael Gorman, Thomas M. Gorrie, Joel Hay, The Hon. Rush Holt, Nien-he Hsieh, Juhana E. Indapaan-Heikkila, Greg Koski, M. Dianne Murphy, Robert M. Nelson, Gary R. Noble, Scott C. Ratzan, Meredith B. Rosenthal, James E. Sabin, Michael A. Santoro, Peter Singleton, J. Russell Teagarden, Sidney Taurel, Patricia H. Werhane, William Weldon

Sign In

Please sign in to access your account

Cancel

Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email lecturers@cambridge.org

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.

Cancel

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×